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Abstract: This study examined whether consuming casein protein (CP) pre-sleep could accelerate
acute recovery following muscle-damaging exercise. Thirty-nine active males and females performed
100 drop jumps in the morning, consumed their habitual diet during the day, and then within
30 min pre-bed consumed either ~40 g of CP (n = 19) or ~40 g of a carbohydrate-only control
(CON) (n = 20). Maximal isometric voluntary contractions (MIVC), countermovement jumps (CMJ),
pressure-pain threshold (PPT), subjective muscle soreness and the brief assessment of mood adapted
(BAM+) were measured pre, 24 and 48 h following the drop jumps. MIVC decreased in CP and
CON post-exercise, peaking at 24 h post (CP: −8.5 ± 3.5 vs. CON: −13.0 ± 2.9%, respectively);
however, no between-group differences were observed (p = 0.486; ηp2 =0.02). There were also no
group differences in the recovery of CMJ height, PPT and BAM+ (p > 0.05). Subjective muscle soreness
increased post-exercise, but no group differences were present at 24 h (CP: 92 ± 31 mm vs. CON:
90 ± 46 mm) or 48 h (CP: 90 ± 44 mm vs. CON: 80 ± 58 mm) (p > 0.05). These data suggest that
pre-bed supplementation with ~40 g of CP is no more beneficial than CON for accelerating the
recovery following muscle-damaging exercise.
Keywords: strength; muscle soreness; nutrition; supplement; exercise recovery
1. Introduction
Unaccustomed and strenuous contractile activity can damage the proteins in muscle and
connective tissues [1,2]. Such damage results in inflammation, swelling, muscle soreness, and a
loss of force-generating capacity [1]. Because these symptoms can persist for several days before
fully recovering, physical activity in the ensuing days might be compromised [1]. This is especially
problematic in athletes who need to train almost daily to develop the requisite technical and physical
abilities for their sport. However, recreationally active and novice exercisers may also be affected, as
tasks required for daily living such as stair climbing and walking can also be impaired in the days
following muscle-damaging exercise [3].
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In an attempt to accelerate the recovery processes and alleviate the deleterious effects of
exercise-induced muscle damage (EIMD), athletes and recreational exercisers alike often supplement
with nutritional products. The most popular recovery supplements tend to be protein-based [4].
The rationale is that protein ingestion stimulates muscle protein synthesis (MPS) and reduces
muscle protein breakdown (MPB) effects, which, at least in theory, help to accelerate myofibrilar
re-conditioning following a damaging insult [4–6]. While individual studies have come to equivocal
conclusions, a recent meta-analysis concluded that whey protein supplementation had small to
moderate benefits for the recovery of muscle function [7]. Thus, the general consensus is that protein
supplementation is likely to facilitate recovery following muscle-damaging exercise.
Because the benefits of post-exercise protein supplementation are linked to increased MPS,
it would be reasonable to assume that maximising this response in the 24 h following muscle-damaging
exercise would help to expedite the recovery process. During the day, MPS can be maximised by
consuming 0.4 g·kg−1 of a leucine rich protein source every 2–3 h or 3–4 times per day [8]. However,
this pattern of eating does not appear to influence overnight MPS, which tends to be low even when
20–30 g of protein is consumed late in the evening (~20:00–22:00) [9–11]. To potentiate overnight
MPS, an additional bolus of protein appears to be required closer to sleep. Indeed, in a series of
recent studies, it has been shown that ingesting a large bolus (~40 g) of slowly digestible casein
protein (CP) within 30 min of going to sleep (~23:30) increases overnight MPS and whole body net
protein balance [9,12–14]. Indeed, some of these studies showed that overnight MPS rates are 22–33%
higher when ~40 g of CP compared to an isocaloric carbohydrate drink is consumed 30 min prior to
sleep [9,10]. These findings suggest that pre-sleep CP intake might be a strategic opportunity to further
augment myofibrilar re-synthesis over a 24 h period.
Two recent studies have exploited the effects of pre-sleep protein ingestion for its potential to
ameliorate EIMD when exercise is performed late in the evening. West et al. [15] showed that ingesting
25 g of whey protein pre-sleep accelerated the recovery of strength and power 24 h after a bout of
evening resistance exercise (19:00). Similarly, we showed that ingesting ~40 g of CP pre-sleep attenuated
muscle soreness and enhanced the recovery of muscle function in the 60 h following an evening soccer
match (19:00) [16]. These studies suggest that pre-sleep protein ingestion might facilitate recovery
when exercise is performed in the evening. However, whether such effects are observed when exercise
is performed in the morning—and there are plenty of opportunities for regular protein servings before
sleep—is unknown. Because MPS is potentiated by prior resistance exercise, pre-sleep CP ingestion
appears to have greater effects on overnight MPS and myofibrilar re-conditioning when exercise is
performed later in the evening [12,13]. Yet, theoretically, stimulating overnight MPS would increase
the overall MPS response in the 24 h following the exercise bout and, thus, if total protein intake
throughout the course of a day is the major determinant of muscle protein accretion—as suggested by
many [17,18]—such a strategy could still augment muscle protein turnover and possibly functional
recovery. Thus, the aim of the present study was to examine whether consuming an additional bolus
of casein protein (CP) pre-sleep could accelerate acute functional recovery following muscle-damaging
exercise performed in the morning. We hypothesised that muscle soreness and muscle function deficits
would be attenuated by pre-sleep CP ingestion.
2. Methods
2.1. Participants
Forty healthy physically active males and females (defined as performing moderate intensity
exercise ≥2 days per week) provided written informed consent to participate in this study (see Table 1
for physical characteristics). One of the participants did not consume their entire supplement
and therefore was excluded from the data analysis; thus, final data analysis was performed on
39 participants (19 females and 20 males). Participants underwent a health screening and were
excluded if they did not agree to avoid using any dietary supplements (i.e., multivitamins, whey
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protein, and creatine), pain relief medications (i.e., nonsteroidal anti-inflammatory drugs), or putative
recovery treatments (i.e., compressions garments, massage) throughout testing. To control for the
potential influence of different menstrual cycle phases on EIMD, we asked all female participants to
complete a menstrual cycle questionnaire at familiarisation [19,20] and used this to schedule testing
during the same monthly phase (follicular). There is some suggestion that males and females respond
differently to muscle damaging exercise and possibly even protein ingestion [21]; therefore, we also
performed a sub-group analysis of the data for males and females separately to test for any sex-specific
effects. The study procedures received ethical approval from Newcastle University (14733882).
Table 1. Participants’ physical characteristics and macronutrient intake in the 24 h following exercise.
Characteristics and Dietary Intake CP (n = 19) CON (n = 20)
Age (years) 23 ± 2 24 ± 3
Sex 10 males, 9 females 10 males, 10 females
Body mass (kg) 67.9 ± 11.2 69.9 ± 12.8
Height (cm) 1.71 ± 0.81 1.73 ± 0.96
Daily energy intake (kcal·kg−1) * 28.70 ± 7.19 [31.89 ± 7.09] 32.68 ± 11.13 [35.41 ± 11.29]
Carbohydrate (g·kg−1) * 3.69 ± 0.95 [3.72 ± 0.95] # 4.09 ± 1.53 [4.72 ± 1.56]
Protein (g·kg−1) * 1.50 ± 0.52 [2.12 ± 0.51] # 1.58 ± 0.59 [1.60 ± 0.59]
Fat (g·kg−1) * 1.00 ± 0.46 [1.04 ± 0.46] 1.19 ± 0.51 [1.20 ± 0.51]
* Values in brackets represents intake with pre-sleep casein protein (CP) or carbohydrate-only control (CON)
supplement. # denotes group difference with supplementation (p < 0.05).
2.2. Experimental Protocol
The study used a randomised, double blind, placebo-controlled, independent groups design.
Following familiarisation, in which height (cm), body mass (kg), maximum isometric voluntary
contraction (MIVC) and counter movement jump height (CMJ) were collected, participants
were randomly allocated into a casein protein (CP) or carbohydrate-only control (CON) group.
The participant groups were matched on this initial MIVC score. Within seven days of the
familiarisation, participants visited the laboratory for three consecutive testing days (between 07:30
and 09:00). On day 1, participants arrived fasted and baseline values for muscle soreness, pressure
pain threshold, CMJ, MIVC and subjective wellbeing were recorded. They then completed 100 drop
jumps, designed to induce muscle damage. Following this, participants consumed a whey protein
supplement (see Table 2 for nutritional composition) and were provided with either a CP or CON
supplement to be consumed before bed (10:00–11:30). The participants returned to the lab 24 and 48 h
following the jumps to repeat the dependent variables.
Table 2. Macronutrient composition of supplements.
Supplement PRO + CHO * CP CON
Energy (Kcal) 271.0 210.0 184.0
Carbohydrate (g) 38.0 4.9 42.8
Protein (g) 24.0 41.2 1.3
Fat (g) 2.6 2.9 0.8
* Recovery drink consumed by all participants immediately post-exercise. CP, casein protein; CON,
carbohydrate-only control.
2.3. Muscle-Damaging Protocol
To induce muscle damage, participants performed 100 drop jumps (4 sets of 25, separated by
2 min of passive recovery) from a 60 cm high box. For the jumps, they dropped off the box and then
immediately performed a vertical jump. Participants were instructed to descend to 90◦ knee flexion
for each jump and received verbal cues to ensure the vertical jump was performed with maximal effort
(e.g., they jumped as high as possible) and correct technique was maintained throughout. The jumps
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were performed every 10 seconds. We have previously found this protocol to be a reliable method of
inducing muscle damage in a young, active population [22,23].
2.4. Muscle Soreness
Subjective muscle soreness was assessed with a visual analogue scale (VAS). Participants
descended to 90◦ of knee flexion and rated the level of pain in their lower limbs on a 200 mm
scale anchored by the terms “no soreness” and “unbearably painful” on each end.
2.5. Pressure Pain Threshold
PPT was measured with a handheld algometer (Wagner Instruments, Greenwich, Conn., USA)
and with the participant lying supine. As in several previous studies [22,23], PPT was recorded
at the following three sites: vastus lateralis (mid-way between the superior aspect of the greater
trochanter and head of the tibia), rectus femoris (mid-way between the anterior patella and inguinal
fold), and gastrocnemius (medial aspect of the calf at relaxed maximum girth). PPT was measured
by applying constant pressure to each of these sites until the participant indicated that they felt pain.
This was done twice, unless the values differed by more than 10 N, then a third recording was taken,
and the average of the two closest values was used for data analysis. The inter-day coefficient of
variance (CV) for this protocol was calculated as <12%.
2.6. Counter Movement Jump
An Opto-jump system was used to measure CMJ performance (Optojump Next, Bolzano, Italy).
This procedure has been described in detail elsewhere [22,23]. Briefly, with hands on hips, participants
descended into a squat position before jumping vertically with maximum effort. Three efforts were
performed; each was separated by a 60 s recovery period. The peak value was used for analysis.
The CV for this procedure was <2.5%.
2.7. Maximum Voluntary Isometric Contraction
As described previously [22], MIVC was measured using a portable strain gauge (MIE Medical
Research Ltd., Leeds, UK). In a seated position at a 90◦ knee angle participants pushed with maximal
force against a perspex gauze attached to their right ankle just above the malleoli. The three attempts
were separated by 60 seconds of recovery; the peak value was used for analysis. The CV for this
procedure has been calculated as <4% in our laboratory.
2.8. Supplementation
The nutritional composition of each supplement is provided in Table 2. Following the drop
jumps, each participant consumed the same whey protein + carbohydrate drink (Science in Sport;
REGO Rapid Recovery; chocolate flavour). This drink was provided to all participants to standardize
post-exercise protein intake [24] and reflect real-world practices, which recommend a fast absorbing
protein be consumed within 60 min of exercise cessation (Aragon et & Schoenfeld, 2013). Participants
were also given either a CP drink (Micellar casein protein, Myprotein, UK) or a CON (Maltodextrin,
Myprotein, UK) with instructions to consume this with ~350 ml of water within 30 min before bed.
We chose a CP dose of ~40 g, as this appears to the most effective dose for maximally stimulating
overnight MPS [10,14]. Both supplements were flavour matched by adding 7.5 g of a low-calorie
chocolate powder (Cadburys Highlights, Hershey, PA, USA). The drinks were prepared in identical
500 mL bottles by an individual not involved in data collection.
2.9. Performance Readiness
Performance readiness was assessed with the Brief Assessment of Mood adapted (BAM+)
developed by Shearer et al. [25]. The BAM+ is comprised of 10 questions relating to individuals
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subjective wellbeing and has been described in detail elsewhere [25]. Example questions include ‘How
well do you feel you’ve slept?’ and ‘how confident do you feel?’. Each question was answered by
marking a line on a 100 mm VAS anchored by ‘not at all’ and ‘extremely well’ at each end. These lines
were measured with a ruler and an overall score calculated.
2.10. Dietary and Exercise Control
Participants abstained from exercise from 48 h prior to the exercise protocol until the end of the
testing period. Participants did not alter their habitual intakes but were required to keep a 3-day food
diary (Intake24, Newcastle University, UK).
3. Data Analysis
All data are expressed as mean ± standard deviation (SD) and statistical significance was set at
p < 0.05 prior to analyses. MIVC, CMJ, muscle soreness (MS), PPT and BAM+ values were analysed
using a mixed model analysis of variance (ANOVA) with two treatment levels (CP vs. CON) and
three repeated measures time points (before exercise; PRE, 24 h and 48 h post-exercise). Separate
ANOVAs were performed for male subjects, female subjects, and all subjects (both males and females).
Another ANOVA was performed to examine any differences in the dependent variables in males vs.
females, irrespective of supplementation. CMJ, PPT for males-only analysis and VAS and PPT for
females-only analysis were not normally distributed (based on p < 0.05 on the Kolmogorov–Smirnov
test) and therefore log transformed for analysis. Least significance difference (LSD) post hoc tests
were performed if a main time, interaction or group effect was observed (p ≤ 0.05). If sphericity was
violated, Greenhouse–Geisser adjustments were used. Multiple Student’s t-tests were used to analyse
group differences in physical characteristics and dietary intakes. All data were analysed using IBM
SPSS Statistics 23 for Windows (Surrey, UK). Partial-eta2 (ηp2) effect size statistics are presented and
were considered either small (0.01–0.06), medium (0.06–0.14) or large (≥0.14) changes.
4. Results
There were no between-group differences in participants physical characteristics (p > 0.05) and
macronutrient intakes (energy, carbohydrate, protein and fat) the day before and the day following
the exercise test (data not shown; p > 0.05). In the 24 h following exercise, there were no differences
in habitual intakes between the two groups (this includes the post-exercise protein drink that all
participants consumed; p > 0.05; Table 1). However, as expected, with the pre-sleep interventions,
protein intake was greater and carbohydrate intake lower in the CP group (p < 0.05; Table 1).
4.1. All Participants
After exercise, the magnitude of muscle damage, as indicated by changes in the dependent
variables, did not differ between the males and females (n = 20 vs. n = 19, respectively), suggesting
that sex did not have a significant influence on the functional markers of exercise recovery (interaction
effect; p > 0.05).
Data for all participants for analysis of CON vs. CP is presented in Figure 1. Subjective muscle
soreness was increased and PPT decreased post-exercise (time effects; p < 0.05) but no interaction effects
were present for either measure (p > 0.05). There was a time effect for CMJ (p = 0.001; ηp2 = 0.20) which
was reduced by 5–10% 24 h post-exercise. No interaction effects for CMJ were observed (p = 0.211;
ηp
2 = 0.042). Similarly, MIVC decreased post-exercise (time effect; p = 0.001; ηp2 = 0.24). At 24 h post,
MIVC was reduced by 37 N in CP and 61 N in CON; no interaction effects were present (p = 0.486;
ηp
2 = 0.02). There were no time or interaction effects for BAM+ (p > 0.05).
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Figure 1. and (a) Countermovement jump (CMJ) height; (b) maximal isometric voluntary contractions
(MIVC); (c) subjective muscle soreness (VAS); (d) pressure pain threshold (PPT); (e) Brief assessment
of mood adapted (BAM+) in all participants pre, 24 and 48 h following muscle damaging exercise. CP,
casein protein; CON, carbohydrate-only control. * denotes significant time effect (p < 0.05).
4.2. Females
Data for female participants is presented in Figure 2. For females, muscle soreness increased
and PPT decreased post-exercise (time effect; p > 0.05). Muscle soreness peaked at 24 h in CON
(92.5 ± 30.0 mm) and at 48 h in CP (115.5 ± 35.8 mm). No interaction effects were observed for
muscle soreness or PPT (p = 0.456; ηp2 = 0.37 and p = 0.21; ηp2 = 0.09, respectively). MIVC was
reduced by 10–15% 24 and 48 h post-exercise (time effect; p = 0.001; ηp2 = 0.47) but there were no
between-group differences (interaction effect; p = 0.683; ηp2 = 0.02). CMJ performance was similarly
decreased post-exercise (p = 0.001; ηp2 = 0.441) and there was no group interaction effect (p = 0.966;
ηp
2 = 0.02). BAM+ scores tended to be lower post-exercise (p = 0.064; ηp2 = 0.150) but there were no
interaction effects (p = 0.655; ηp2 = 0.02).
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4.3. Males
Data for male participants is presented in Figure 3. Muscle soreness increased and PPT decreased
in both groups at 24 and 48 h post-exercise (time effect; p > 0.05); however, no interaction effects were
observed for either subjective soreness (p = 0.854; ηp2 = 0.07) or PPT (p = 0.316; ηp2 = 0.06). CMJ height
did not fall below baseline levels at any time point post-exercise (time effect; p = 0.143; ηp2 = 0.10)
and no interaction effects were present (p = 0.142; ηp2 = 0.10). At 24 post-exercise CMJ height was
−9.4 ± 14.7% in the CON group and −3.7 ± 4.0 in the CP group. MIVC decreased post-exercise
(time effect; p = 0.02; ηp2 = 0.18) but there were no between-group differences at any time point
(p = 0.226; ηp2 = 0.07). The BAM+ showed no time (p = 0.532; ηp2 = 0.29) or interaction effects (p = 0.585;
ηp
2 = 0.02).
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Figure 3. (a) Countermovement jump (CMJ) height; (b) maximal isometric voluntary contractions
(MIVC); (c) subjective muscle soreness (VAS); (d pressure pain threshold (PPT); (e) Brief assessment of
mood adapted (BAM+) in male participants pre, 24 and 48 h following muscle damaging exercise. CP,
casein protein; CON, carbohydrate-only control. * d notes significant time effect (p < 0.05).
5. Discussion
A number of previous studies have reported that ingesting ~40 g of CP within 30 min of sleep
augments overnight MPS rates, resulting in a more positive net protein balance and the formation
of new myofibrilar proteins during sleep (reviewed by [26]). Recent studies suggested that these
effects might translate to improved functional recovery in the days following exercise performed in
the evening e.g., closer to sleep [15,16]. The present study aimed to extend upon these findings and
assess whether CP ingestion might attenuate muscle soreness and decrements in muscle function
when exercise is performed in the morning and followed by a normal pattern of eating with sufficient
protein intake. Contrary to our hypothesis, ingesting a large bolus of CP pre-sleep did not affect
functional recovery in the 48 h following a strenuous bout of eccentrically-biased exercise performed
in the morning, irrespective of sex.
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These findings are in contrast to our recent study in professional soccer players where we
found that ingesting ~40 g of CP before sleep accelerated the recovery of CMJ and reactive strength
performance in the 60 h following an evening soccer match [16]. They are also not in agreement
with the findings of West et al. [15] who reported muscle strength and power recovered quicker
24 h following a bout of resistance exercise when 25 g of whey protein (vs. an isocaloric control)
was consumed pre-sleep. While the discrepancy between these studies and the present study could
be linked to the different training status of the subjects or the exercise modes used, a more likely
explanation relates to the timing of the exercise. It was recently shown that overnight myofibrilar
re-synthesis following pre-sleep CP ingestion is further augmented by prior resistance exercise [12,13],
ostensibly due to the independent effects of contractile activity on MPS—which, although can remain
elevated for up to 48 h, are still attenuated ≥3 h following an exercise bout [8,27]. This suggests that
overnight myofibrilar re-conditioning is probably greater when exercise is performed later in the
evening. As such, the recovery benefits of pre-sleep protein ingestion observed in previous work could
be due to the potentiating effect of the evening exercise bouts on MPS. In contrast, because exercise
was performed in the morning in the present study, the post-exercise anabolic response or heightened
sensitivity to amino acid ingestion could have been sufficiently dissipated when the CP was ingested
to have little or at least a smaller additive benefit [8]. We did not measure muscle protein turnover in
the present study and can therefore only speculate on these effects. However, there is some evidence
to support the contention that augmenting overnight MPS facilitates the recovery of acute muscle
function. Indeed, West et al. [15] showed concurrent improvements in net protein balance and strength
recovery in the 24 h following a bout of resistance exercise. Taking these and the present findings into
consideration, perhaps pre-sleep protein ingestion represents a useful strategy for accelerating the
recovery of muscle function after evening exercise bouts but not when performed in the morning.
A recent study showed that 35 g of CP consumed either during the day or pre-sleep led to similar
improvements in muscle strength and size when combined with 12 weeks of progressive resistance
training [18]. Protein intakes were matched in this study, and so the authors concluded that total
protein intake over the 24 h period following exercise is more important than the timing of intake
when it comes to muscular adaptations. Nonetheless, in the present study, total daily protein intake
was greater in the intervention group—similar to previous studies showing benefits of pre-sleep CP on
muscle protein metabolism [9,10,12,14]—and we still did not observe any positive effects. This could
be because the subject’s habitual protein intake in the 24 h following the exercise bout were already
sufficient to maximise myofibrilar re-conditioning and therefore the additional 40 g intake of CP had
no further benefits—at least for acute functional recovery. Indeed, previous studies have come to the
conclusion that daily protein intakes of 1.2–1.6 g·kg−1 are likely sufficient to maximise muscle protein
turnover and subsequent adaptation [8]. Given that the subjects in both groups ingested ≥1.5 g·kg−1
of protein in the 24 h following exercise (Table 1), the additional protein from the pre-sleep CP might
have offered little further benefit. It is important to note, however, that the aforementioned guidelines
are generally aimed at those looking to maximise chronic muscular adaptations such as hypertrophy.
We are unaware of any specific guidelines or studies that have assessed, in a dose response manner,
the optimal protein intakes for attenuating EIMD. This is an area of research that should be explored
in the future.
The main limitation of this study is that we did not measure MPS or whole-body protein turnover.
We therefore cannot confirm whether the CP intervention did in fact increase overnight MPS. However,
given the extensive number of studies that have now demonstrated these effects, we feel confident that
the intervention would have positively affected overnight MPS rates at least to some extent. We also
think our focus on muscle function markers over MPS measures is a strength of the study, given
they have the most practical relevance for athletic populations and are still the most valid markers of
EIMD [28]. A second potential limitation of this study is that we did not control dietary intake or, more
specifically, directly match protein intakes in the two groups. Although the food diaries indicated
that the macronutrient composition between the CP and CON groups did not differ, the inherent
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limitations of collecting and analysing food diaries means that we cannot rule out the presence of
subtle differences that could have affected the results.
In conclusion, this is the first study to assess the effects of pre-sleep CP ingestion on indirect
markers of EIMD in recreationally active males and females following exercise performed in the
morning. We saw no differences in the recovery markers between males and females and found that
the pre-sleep CP ingestion was no more effective than consuming a carbohydrate-only control for
acute functional recovery. From a practical perspective, our findings suggest that protein intakes of
~1.5 g·kg−1 in the 24 h following muscle-damaging exercise performed in the morning are sufficient
to maximise acute functional recovery, and that no further benefits can be gleaned by consuming an
additional bolus of pre-sleep CP.
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